Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 278014, 13 pages
http://dx.doi.org/10.1155/2015/278014
Research Article

Protective Effects of Scutellarin on Human Cardiac Microvascular Endothelial Cells against Hypoxia-Reoxygenation Injury and Its Possible Target-Related Proteins

1School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China
2Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
3Department of Periodontology and Implant Dentistry, The First People’s Hospital of Yun-Nan Province, Kunhua Hospital, Kunming University of Science and Technology, Kunming 650032, China

Received 4 February 2015; Revised 25 April 2015; Accepted 25 April 2015

Academic Editor: Klaus Heese

Copyright © 2015 Meina Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Wang, J. Mingli, L. Chen, X. Wu, and L. Wang, “Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1322–1326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. H. Shang, J. F. Tian, M. Hou, and X. Y. Xu, “Progress on the protective effect of compounds from natural medicines on cerebral ischemia,” Chinese Journal of Natural Medicines, vol. 11, no. 6, pp. 588–595, 2013. View at Publisher · View at Google Scholar
  3. L. Yiming, H. Wei, L. Aihua, and Z. Fandian, “Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats,” The Journal of Pharmacy and Pharmacology, vol. 60, no. 3, pp. 349–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. X.-L. Li, Y.-Q. Li, W.-M. Yan et al., “A study of the cardioprotective effect of breviscapine during hypoxia of cardiomyocytes in vitro and during myocardial infarction in vivo,” Planta Medica, vol. 70, no. 11, pp. 1039–1044, 2004. View at Publisher · View at Google Scholar
  5. L. L. Lin, A. J. Liu, J. G. Liu, X. H. Yu, L. P. Qin, and D. F. Su, “Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats,” Journal of Cardiovascular Pharmacology, vol. 50, pp. 327–332, 2007. View at Publisher · View at Google Scholar
  6. H. Dai, J. Gu, L.-Z. Li, L.-M. Yang, H. Liu, and J.-Y. Li, “Scutellarin benzyl ester partially secured the ischemic injury by its anti-apoptosis mechanism in cardiomyocytes of neonatal rats,” Journal of Chinese Integrative Medicine, vol. 9, no. 9, pp. 1014–1021, 2011. View at Publisher · View at Google Scholar
  7. Z.-W. Pan, Y. Zhang, D.-H. Mei et al., “Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 381, no. 2, pp. 137–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Radovits, J. Zotkina, L.-N. Lin, M. Karck, and G. Szabó, “Endothelial dysfunction after hypoxia-reoxygenation: do in vitro models work?” Vascular Pharmacology, vol. 51, no. 1, pp. 37–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Laude, P. Beauchamp, C. Thuillez, and V. Richard, “Endothelial protective effects of preconditioning,” Cardiovascular Research, vol. 55, no. 3, pp. 466–473, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Carden and D. N. Granger, “Pathophysiology of ischaemia-reperfusion injury,” The Journal of Pathology, vol. 190, no. 3, pp. 255–266, 2000. View at Publisher · View at Google Scholar
  11. D. S. Burley, P. Ferdinandy, and G. F. Baxter, “Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling,” British Journal of Pharmacology, vol. 152, no. 6, pp. 855–869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. X. Feng, C. J. Jing, K. L. Tang et al., “Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis,” Proteomics, vol. 11, pp. 1473–1485, 2011. View at Publisher · View at Google Scholar
  13. Q.-X. Yue, Z.-W. Cao, S.-H. Guan et al., “Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network,” Molecular & Cellular Proteomics, vol. 7, no. 5, pp. 949–961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yao, W. Y. Wu, S. H. Guan et al., “Proteomic analysis of differential protein expression in rat platelets treated with notoginsengnosides,” Phytomedicine, vol. 15, pp. 800–807, 2008. View at Publisher · View at Google Scholar
  15. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Emily, T. Mailund, J. Hein, L. Schauser, and M. H. Schierup, “Using biological networks to search for interacting loci in genome-wide association studies,” European Journal of Human Genetics, vol. 17, no. 10, pp. 1231–1240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Guo, L.-M. Hu, S.-X. Wang et al., “Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity,” The Chinese Journal of Physiology, vol. 54, no. 6, pp. 399–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. L. Maddock, K. J. Broadley, A. Bril, and N. Khandoudi, “Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: Cardioprotection by activation of adenosine A2A receptors,” Journal of Autonomic Pharmacology, vol. 21, no. 5, pp. 263–271, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. D. Kim, B. Chen, J. Beauregard et al., “17β-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion,” Circulation, vol. 94, no. 11, pp. 2901–2908, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. R. K. Kharbanda, M. Peters, B. Walton et al., “Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo,” Circulation, vol. 103, no. 12, pp. 1624–1630, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. T. Turer and J. A. Hill, “Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy,” The American Journal of Cardiology, vol. 106, no. 3, pp. 360–368, 2010. View at Publisher · View at Google Scholar
  22. F. Sanvito, S. Piatti, A. Villa et al., “The β4 integrin interactor p27(BBP/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly,” The Journal of Cell Biology, vol. 144, no. 5, pp. 823–837, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Basu, K. Si, J. R. Warner, and U. Maitra, “The Saccharomyces cerevisiae TIF6 gene encoding translation initiation factor 6 is required for 60S ribosomal subunit biogenesis,” Molecular and Cellular Biology, vol. 21, no. 5, pp. 1453–1462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Benelli, S. Marzi, C. Mancone, T. Alonzi, A. La Teana, and P. Londei, “Function and ribosomal localization of aIF6, a translational regulator shared by archaea and eukarya,” Nucleic Acids Research, vol. 37, no. 1, pp. 256–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Miluzio, A. Beugnet, V. Volta, and S. Biffo, “Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation,” EMBO Reports, vol. 10, no. 5, pp. 459–465, 2009. View at Publisher · View at Google Scholar
  26. V. Gandin, A. Miluzio, A. M. Barbieri et al., “Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation,” Nature, vol. 455, no. 7213, pp. 684–688, 2008. View at Publisher · View at Google Scholar
  27. C. M. Groft, R. Beckmann, A. Sali, and S. K. Burley, “Crystal structures of ribosome anti-association factor IF6,” Nature Structural Biology, vol. 7, no. 12, pp. 1156–1164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. N. De Marco, L. Iannone, R. Carotenuto, S. Biffo, A. Vitale, and C. Campanella, “p27BBP/eIF6 acts as an anti-apoptotic factor upstream of Bcl-2 during Xenopus laevis development,” Cell Death and Differentiation, vol. 17, no. 2, pp. 360–372, 2009. View at Publisher · View at Google Scholar
  29. A. Donadini, A. Giodini, F. Sanvito, P. C. Marchisio, and S. Biffo, “The human ITGB4BP gene is constitutively expressed in vitro, but highly modulated in vivo,” Gene, vol. 266, no. 1-2, pp. 35–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. P. Perez, L. Pendyala, Z. Elakawi, and M. Abu-Hadid, “RT-PCR quantitation of HSP60 mRNA expression,” in Ovarian Cancer, vol. 39 of Methods in Molecular Medicine, pp. 439–447, Humana Press, 2001. View at Publisher · View at Google Scholar
  31. R. Magnoni, J. Palmfeldt, J. H. Christensen et al., “Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice,” Neurobiology of Disease, vol. 54, pp. 12–23, 2013. View at Publisher · View at Google Scholar
  32. A. S. Bie, J. Palmfeldt, J. Hansen et al., “A cell model to study different degrees of Hsp60 deficiency in HEK293 cells,” Cell Stress& Chaperones, vol. 16, no. 6, pp. 633–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. H. Christensen, M. N. Nielsen, J. Hansen et al., “Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice,” Cell Stress & Chaperones, vol. 15, no. 6, pp. 851–863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Hollander, K. M. Lin, B. T. Scott, and W. H. Dillmann, “Overexpression of PHGPx and HSP60/10 protects against ischemia/ reoxygenation injury,” Free Radical Biology & Medicine, vol. 35, no. 7, pp. 742–751, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. K. M. Lin, B. Lin, I. Y. Lian, R. Mestril, I. E. Scheffler, and W. H. Dillmann, “Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation,” Circulation, vol. 103, no. 13, pp. 1787–1792, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Lau, N. Patnaik, M. Richard Sayen, and R. Mestril, “Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury,” Circulation, vol. 96, no. 7, pp. 2287–2294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Wei, G. Zhu, X. Cui, L. Kang, D. Cao, and Y. Jiang, “Expression of CCT6A mRNA in chicken granulosa cells is regulated by progesterone,” General and Comparative Endocrinology, vol. 189, pp. 15–23, 2013. View at Publisher · View at Google Scholar
  38. P. Bross, R. Magnoni, and A. S. Bie, “Molecular chaperone disorders: defective Hsp60 in neurodegeneration,” Current Topics in Medicinal Chemistry, vol. 12, no. 22, pp. 2491–2503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. L. Asquith, A. J. Harman, E. A. McLaughlin, B. Nixon, and R. J. Aitken, “Localization and significance of molecular chaperones, heat shock protein 1, and tumor rejection antigen gp96 in the male reproductive tract and during capacitation and acrosome reaction,” Biology of Reproduction, vol. 72, no. 2, pp. 328–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Biswas, S. Mukherjee, S. Das, D. Shields, C. W. Chow, and U. Maitra, “Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6,” The Journal of Biological Chemistry, vol. 286, no. 4, pp. 3129–3138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. U. Basu, K. Si, H. Deng, and U. Maitra, “Phosphorylation of mammalian eukaryotic translation initiation factor 6 and its Saccharomyces cerevisiae homologue Tif6p: evidence that phosphorylation of Tif6p regulates its nucleocytoplasmic distribution and is required for yeast cell growth,” Molecular and Cellular Biology, vol. 23, no. 17, pp. 6187–6199, 2003. View at Publisher · View at Google Scholar · View at Scopus